Rhoen Klinikum AG operates in the Specialty hospitals exc. psychiatric sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rhoen Klinikum AG with three other
health care providers in Europe:
sales of 626.41 million Euro [US$708.61 million]
of which 60%
was Post Acute),
Capio AB (publ)
(15.33 billion Swedish Kronor [US$1.66 billion]
of which 57%
was Nordic), and
Spire Healthcare Group PLC
based in the United Kingdom
(£931.70 million [US$1.20 billion]
of which 100%
was Healthcare Services).
Rhoen Klinikum AG reported sales of 1.21 billion Euro (US$1.37 billion)
December of 2017.
increase of 3.0%
versus 2016, when the company's sales were 1.18 billion Euro.
Sales of Inpatient Hospitals saw an increase
that was more than double the company's growth rate: sales were up
13.0% in 2017, from
10.80 million Euro to 12.20 million Euro.
Not all segments of Rhoen Klinikum AG experienced an increase in sales in 2017:
sales of Rehabilitation fell 1.9% to 25.70 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).